Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SR 47063

Known as: SR-47063, SR47063 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Chromans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Recognition of Sulfonylurea Receptor (ABCC8/9) Ligands by the Multidrug Resistance Transporter P-glycoprotein (ABCB1)
ATP-sensitive K+ (KATP) channels are the target of a number of pharmacological agents, blockers like hypoglycemic sulfonylureas… Expand
  • table 1
  • table 2
  • table 3
2009
2009
Impact of Disease-causing SUR1 Mutations on the KATP Channel Subunit Interface Probed with a Rhodamine Protection Assay*
The function of the ATP-sensitive potassium (KATP) channel relies on the proper coupling between its two subunits: the pore… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2006
2006
Interaction of KATP Channels and Endothelin-1 in Lambs With Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn is a life-threatening condition in which half of infants fail to respond to… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2005
2005
The Size of a Single Residue of the Sulfonylurea Receptor Dictates the Effectiveness of KATP Channel Openers
KATP channel openers are a diverse group of molecules able to activate ATP-sensitive K+ channels in a tissue-dependent manner by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
SR47063, A potent channel opener, activates KATP and a time-dependent current likely due to potassium accumulation
Abstract(i) We studied the effects of a new cromakalim analogue, SR47063, in guinea-pig ventricular cells. The experiments were… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2000
2000
Vasorelaxant effects of the potassium channel opener SR 47063 on the isolated human saphenous vein and rat aorta.
The vasorelaxant effects of SR 47063 (4-(2-cyanimino-1, 2-dihydropyrid-1-yl)-2,2-dimethyl-6-nitr ochromene), a new K(+)-channel… Expand
  • figure 1
  • table 1
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE